GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (STU:7PO) » Definitions » Shares Buyback Ratio %

Poxel (STU:7PO) Shares Buyback Ratio % : -42.24 (As of Dec. 11, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Poxel Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Poxel's current shares buyback ratio was -42.24%.

Poxel Shares Buyback Ratio % Historical Data

The historical data trend for Poxel's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Poxel Shares Buyback Ratio % Chart

Poxel Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shares Buyback Ratio %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.77 -9.24 -0.68 -5.00 -28.30

Poxel Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.03 -3.92 -13.56 -12.98 -25.90

Poxel Shares Buyback Ratio % Calculation

Poxel's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Dec. 2022 ) - Shares Outstanding (EOP) (A: Dec. 2023 )) / Shares Outstanding (EOP) (A: Dec. 2022 )
=(30.0887 - 38.6026) / 30.0887
=-28.30%

Poxel's Shares Buyback Ratio for the quarter that ended in Dec. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Jun. 2023 ) - Shares Outstanding (EOP) (A: Dec. 2023 )) / Shares Outstanding (EOP) (A: Jun. 2023 )
=(34.1691 - 38.6026) / 34.1691
=-12.98%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poxel Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Poxel's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Poxel Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Poxel SA (STU:7PO) » Definitions » Shares Buyback Ratio %
Comparable Companies
XPAR:FALG XPAR:ALHYG XPAR:ALCOX XPAR:ALTHX XPAR:ALNFL XPAR:ALPAT XPAR:ALINT XPAR:ALVET XPAR:SIGHT XPAR:ALBPS OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
0RA2:UK POXEL:France
Address
259/261 Avenue Jean Jaures, Immeuble le Sunway, Lyon, FRA, 69007
Website
https://www.poxel.com
Poxel SA is a biopharmaceutical company. It is focused on the development of novel treatments for metabolic diseases, including type 2 diabetes and liver diseases, such as nonalcoholic steatohepatitis (NASH) and rare disorders (ALD/AMN). It has developed a portfolio of drug candidates, including its candidates: Imeglimin, for the treatment of type 2 diabetes, and PXL770 and PXL065, for the treatment of NASH.

Poxel Headlines

No Headlines